NSC-60339
CAS No. 70-09-7
NSC-60339 ( —— )
产品货号. M22105 CAS No. 70-09-7
NSC-60339 是一种外排泵抑制剂,也是 AcrAB-TolC 的底物,是一种多元对苯二甲酸衍生物,被研究作为潜在的癌症化疗剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥1511 | 有现货 |
|
| 10MG | ¥2214 | 有现货 |
|
| 25MG | ¥3432 | 有现货 |
|
| 50MG | ¥4622 | 有现货 |
|
| 100MG | ¥5877 | 有现货 |
|
| 200MG | ¥7911 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称NSC-60339
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述NSC-60339 是一种外排泵抑制剂,也是 AcrAB-TolC 的底物,是一种多元对苯二甲酸衍生物,被研究作为潜在的癌症化疗剂。
-
产品描述NSC-60339 is an inhibitor of efflux pump, and a substrate of AcrAB-TolC, is a polybasic terephthalic acid derivative studied as a potential cancer chemotherapeutic agent.
-
体外实验NSC 60339 has been correlated with the sensitivity, resistance, or cross-resistance of 7 tumor lines to phthalanilide treatment in vivo. The sensitive tumors (L1210, L1210/MTX, L1210/ara-C, and P815) rapidly takes up the drug and retained it primarily as lipid-bound drug for the 24-hr experimental period. The resistant tumor, L1210/NSC 60339, and 2 cross-resistant tumors, P388/VCR and P815/VLB, took up as much drug as the sensitive tumors did by 0.5 hr, but there was an efflux of lipid-bound drug from these resistant tumors by 24 hr.
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体efflux pump
-
研究领域——
-
适应症——
化学信息
-
CAS Number70-09-7
-
分子量486.95
-
分子式C26H23ClN6O2
-
纯度>98% (HPLC)
-
溶解度DMSO:4.5 mg/mL?(9.24 mM;?Need ultrasonic)
-
SMILESClc1cc(ccc1C(=O)Nc1ccc(cc1)C1=NCCN1)C(=O)Nc1ccc(cc1)C1=NCCN1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Haynes KM, et al. Identification and Structure-Activity Relationships of Novel Compounds that Potentiate the Activities of Antibiotics in Escherichia coli. J Med Chem. 2017 Jul 27;60(14):6205-6219.
产品手册
关联产品
-
Anti-Inflammatory Pe...
Antiflammin 2 抑制血小板激活因子 (PAF) 的合成,IC50 为 100 nM。
-
1,3-Dibromo-5,5-dime...
1,3-Dibromo-5,5-二甲基乙内酰脲是一种基于烷基链的 PROTAC 连接体,可用于 PROTAC 的合成。
-
Methyl purple
甲基紫是一种引入的醌酰亚胺氧化还原染料。
021-51111890
购物车()
sales@molnova.cn

